This briefing details the FDA-cleared ER-100 gene therapy trial using truncated Yamanaka factors for ocular age reprogramming, highlighting…
OpenAI’s retirement of GPT-4o by 2026 highlights AI safety challenges from engagement-driven model design, legal liabilities including wrongful-death…
Analysis of how family-driven geographic mobility, enabled by digital infrastructure and global visa programs, is transforming talent distribution,…

The briefing analyzes the longevity sector’s transformation into an $8 trillion market by 2030, emphasizing aging as a…
Sinceerly is an AI-driven browser plugin that intentionally degrades text quality by adding typos and stylistic flaws to…